A pilot study of intravitreal bevacizumab for the treatment of central serous chorioretinopathy (Case reports)

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 246, Issue 9, 2008, Pages 1235-1239

  Torres Soriano, Mitzy E ^a   García Aguirre, Gerardo ^a   Kon Jara, Verónica ^a   Ustariz Gonzáles, Orlando ^a   Abraham Marín, Maura ^a   Ober, Michael D ^b,c   Quiroz Mercado, Hugo ^a  

^a HOSPITAL DR LUIS SÁNCHEZ BULNES   (Mexico)

^b EAR AND THROAT HOSPITAL   (United States)

^c VITREOUS RETINA MACULA CONSULTANTS OF NEW YORK   (United States)

Author keywords

Central serous chorioretinopathy; Intravitreal bevacizumab; Retinal pigment epithelium detachment

Indexed keywords

BEVACIZUMAB;

ADULT; ARTICLE; CASE REPORT; CENTRAL SEROUS RETINOPATHY; FEMALE; FOLLOW UP; HUMAN; MALE; OPTICAL COHERENCE TOMOGRAPHY; PILOT STUDY; PRIORITY JOURNAL; RETINA DETACHMENT; RETINA FLUORESCEIN ANGIOGRAPHY; RETINA PIGMENT EPITHELIOPATHY; VISUAL ACUITY;

ADULT; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; CHORIORETINITIS; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; INJECTIONS; MALE; MIDDLE AGED; PIGMENT EPITHELIUM OF EYE; PILOT PROJECTS; SERUM; TOMOGRAPHY, OPTICAL COHERENCE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY; VITREOUS BODY;

EID: 48449083711     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-008-0856-x     Document Type: Article

References (15)

1. Avery RL, Pieramici DJ, Rabena MD, Castellarin AA, Nasir MA, Giust MJ (2006) Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmology 113:363-372
2. Battaglia Parodi M, Da Pozzo S, Ravalico G (2003) Photodynamic therapy in chronic central serous chorioretinopathy. Retina 23:235-237
3. Bujarborua D (2005) CSR: Idiopathic central serous chorioretinopathy. Jaypee Brothers, New Delhi
4. Burumcek E, Mudun A, Karacorlu S, Arslan MO (1997) Laser photocoagulation for persistent central serous retinopathy: Results of long-term follow-up. Ophthalmology 104:616-622
5. Cardillo Piccolino F, Eandi CM, Ventre L et al (2003) Photodynamic therapy for chronic central serous chorioretinopathy. Retina 23:752-763
6. Chan WM, Lam DS, Lai TY et al (2003) Choroidal vascular remodeling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: A novel treatment at the primary disease level. Br J Ophthalmol 87:1453-1458
7. Colucciello M (2006) Choroidal neovascularization complication photodynamic therapy for central serous retinopathy. Retina 26:239-242
8. Gass JD (1967) Pathogenesis of disciform detachment of the neuroepithelium. Am J Ophthalmol 63(Suppl):1-139
9. Heiduschka P, Fietz H, Hofmeister S, Schultheiss S, Mack AF, Peters S, Ziemssen F, Niggemann B, Julien S, Bartz-Schmidt KU, Schraermeyer U (2007) Tübingen bevacizumab study group. Penetration of bevacizumab through the retina after intravitreal injection in the monkey. Invest Ophthalmol Vis Sci 48:2814-2823
10. Ober MD, Eandi CM, Jampol LM, Fine HF, Yannuzzi LA (2007) Focal retinal pigment epithelium breaks in central serous chorioretinopathy. Retinal Cases and Brief Reports 1(4):271-274
11. Ober MD, Yannuzzi LA, Do DV et al (2005) Photodynamic therapy for focal retinal pigment epithelial leaks secondary to central serous chorioretinopathy. Ophthalmology 112:2088-2094
12. Pikkel J, Beiran I, Ophir A, Miller B (2002) Acetazolamide for central serous retinopathy. Ophthalmology 109:1723-1725
13. Shahar J, Avery RL, Heilweil G, Barak A, Zemel E, Lewis GP, Johnson PT, Fisher SK, Perlman I, Loewenstein A (2006) Electrophysiologic and retinal penetration studies following intravitreal injection of bevacizumab (Avastin). Retina 26:262-269
14. Spaide RF, Laud K, Fine HF et al (2006) Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration. Retina 26:383-390
15. Von Graefe A (1866) Ueber centrale recidivierende Retinitis. Graefes Arch Clin Exp Ophthalmol 12:211-215